• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LI-RADS v2017 用于肝脏结节:我们的阅读和报告方法。

LI-RADS v2017 for liver nodules: how we read and report.

机构信息

Department of Diagnostic and Interventional Radiology, Goettlicher Heiland Krankenhaus, Barmherzige Schwestern Krankenhaus, and St. Josef Krankenhaus, Vienna, Austria.

Mayo Clinic, Rochester, Minnesota, USA.

出版信息

Cancer Imaging. 2018 Apr 24;18(1):14. doi: 10.1186/s40644-018-0149-5.

DOI:10.1186/s40644-018-0149-5
PMID:29690933
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5978995/
Abstract

The Liver Imaging Reporting and Data System (LI-RADS) standardizes the interpretation and reporting of imaging examinations in patients at risk for hepatocellular carcinoma (HCC). For focal liver observations it assigns categories (LR-1 to 5, LR-M, LR-TIV), which reflect the relative probability of benignity or malignancy of the respective observation. The categories assigned are based on major and ancillary image features, which have been developed by the American College of Radiology (ACR) and validated in many studies. This review summarizes the relevant CT and MRI features and presents an image-guided approach for readers not familiar with LI-RADS on how to use the system. The widespread adoption of LI-RADS for reporting would help reduce inter-reader variability and improve communication among radiologists, hepatologists, hepatic surgeons and oncologists, thus leading to improved patient management.

摘要

肝脏影像报告和数据系统(LI-RADS)标准化了肝细胞癌(HCC)高危患者的影像学检查的解释和报告。对于局灶性肝脏观察,它分配类别(LR-1 至 5、LR-M、LR-TIV),反映了各自观察的良性或恶性的相对可能性。分配的类别基于主要和辅助图像特征,这些特征由美国放射学院(ACR)开发,并在许多研究中得到验证。这篇综述总结了相关的 CT 和 MRI 特征,并为不熟悉 LI-RADS 的读者提供了一种图像引导的方法,介绍如何使用该系统。广泛采用 LI-RADS 进行报告将有助于减少读者间的变异性,并改善放射科医生、肝病专家、肝外科医生和肿瘤学家之间的沟通,从而改善患者管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91e/5978995/f0ea148d837e/40644_2018_149_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91e/5978995/b98476ea07e3/40644_2018_149_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91e/5978995/5ad2715d74aa/40644_2018_149_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91e/5978995/e29881ba7183/40644_2018_149_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91e/5978995/1ebf87c0d01c/40644_2018_149_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91e/5978995/3bf2cbb63312/40644_2018_149_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91e/5978995/b0128421db7c/40644_2018_149_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91e/5978995/6c1c1e612c36/40644_2018_149_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91e/5978995/b07300ffd02a/40644_2018_149_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91e/5978995/a83b4e9b9abc/40644_2018_149_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91e/5978995/11d4ee7524cf/40644_2018_149_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91e/5978995/dddf13a20a9f/40644_2018_149_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91e/5978995/55a975e854ca/40644_2018_149_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91e/5978995/c8f16a90e1bc/40644_2018_149_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91e/5978995/f0ea148d837e/40644_2018_149_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91e/5978995/b98476ea07e3/40644_2018_149_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91e/5978995/5ad2715d74aa/40644_2018_149_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91e/5978995/e29881ba7183/40644_2018_149_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91e/5978995/1ebf87c0d01c/40644_2018_149_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91e/5978995/3bf2cbb63312/40644_2018_149_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91e/5978995/b0128421db7c/40644_2018_149_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91e/5978995/6c1c1e612c36/40644_2018_149_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91e/5978995/b07300ffd02a/40644_2018_149_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91e/5978995/a83b4e9b9abc/40644_2018_149_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91e/5978995/11d4ee7524cf/40644_2018_149_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91e/5978995/dddf13a20a9f/40644_2018_149_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91e/5978995/55a975e854ca/40644_2018_149_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91e/5978995/c8f16a90e1bc/40644_2018_149_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91e/5978995/f0ea148d837e/40644_2018_149_Fig14_HTML.jpg

相似文献

1
LI-RADS v2017 for liver nodules: how we read and report.LI-RADS v2017 用于肝脏结节:我们的阅读和报告方法。
Cancer Imaging. 2018 Apr 24;18(1):14. doi: 10.1186/s40644-018-0149-5.
2
LI-RADS Made Easy.LI-RADS 易读版。
Rofo. 2023 Jun;195(6):486-494. doi: 10.1055/a-1990-5924. Epub 2023 Feb 1.
3
Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy?肝细胞癌:钆塞酸增强磁共振和弥散加权成像的 LI-RADS v2017 能否提高诊断准确性?
World J Gastroenterol. 2019 Feb 7;25(5):622-631. doi: 10.3748/wjg.v25.i5.622.
4
2017 Version of LI-RADS for CT and MR Imaging: An Update.2017 版 CT 和 MR 成像肝脏影像学报告和数据系统:更新。
Radiographics. 2017 Nov-Dec;37(7):1994-2017. doi: 10.1148/rg.2017170098.
5
Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review.支持LI-RADS主要特征用于基于CT和MRI成像诊断肝细胞癌的证据:一项系统评价
Radiology. 2018 Jan;286(1):29-48. doi: 10.1148/radiol.2017170554. Epub 2017 Nov 21.
6
LI-RADS ancillary features on CT and MRI.LI-RADS 在 CT 和 MRI 上的辅助特征。
Abdom Radiol (NY). 2018 Jan;43(1):82-100. doi: 10.1007/s00261-017-1220-6.
7
Diagnostic Performance of LI-RADS Version 2018, LI-RADS Version 2017, and OPTN Criteria for Hepatocellular Carcinoma.LI-RADS 版本 2018、LI-RADS 版本 2017 和 OPTN 标准用于诊断肝细胞癌的性能比较。
AJR Am J Roentgenol. 2020 Nov;215(5):1085-1092. doi: 10.2214/AJR.20.22772. Epub 2020 Sep 2.
8
Diagnostic performance of MR for hepatocellular carcinoma based on LI-RADS v2018, compared with v2017.基于 LI-RADS v2018 的肝细胞癌的 MRI 诊断性能,与 v2017 相比。
J Magn Reson Imaging. 2019 Sep;50(3):746-755. doi: 10.1002/jmri.26640. Epub 2019 Jan 15.
9
Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy-A Systematic Review.肝脏成像报告和数据系统在肝细胞癌或总体恶性肿瘤的计算机断层扫描和磁共振成像分析中的准确性:系统评价。
Gastroenterology. 2019 Mar;156(4):976-986. doi: 10.1053/j.gastro.2018.11.020. Epub 2018 Nov 13.
10
LI-RADS Version 2018 Ancillary Features at MRI.LI-RADS Version 2018 磁共振成像辅助特征。
Radiographics. 2018 Nov-Dec;38(7):1973-2001. doi: 10.1148/rg.2018180052. Epub 2018 Oct 5.

引用本文的文献

1
[Multiparametric magnetic resonance imaging for hepatocellular carcinoma, part 1 : Morphology and dynamic perfusion imaging in primary diagnostics and treatment monitoring].[肝细胞癌的多参数磁共振成像,第1部分:在初步诊断和治疗监测中的形态学及动态灌注成像]
Radiologie (Heidelb). 2024 Apr;64(4):321-332. doi: 10.1007/s00117-024-01285-1. Epub 2024 Mar 19.
2
Prediction microvascular invasion of hepatocellular carcinoma based on tumour margin enhancing pattern in multiphase computed tomography images.基于多期计算机断层扫描图像中肿瘤边缘强化模式预测肝细胞癌微血管侵犯
Pol J Radiol. 2023 May 10;88:e238-e243. doi: 10.5114/pjr.2023.127578. eCollection 2023.
3

本文引用的文献

1
Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review.支持LI-RADS主要特征用于基于CT和MRI成像诊断肝细胞癌的证据:一项系统评价
Radiology. 2018 Jan;286(1):29-48. doi: 10.1148/radiol.2017170554. Epub 2017 Nov 21.
2
2017 Version of LI-RADS for CT and MR Imaging: An Update.2017 版 CT 和 MR 成像肝脏影像学报告和数据系统:更新。
Radiographics. 2017 Nov-Dec;37(7):1994-2017. doi: 10.1148/rg.2017170098.
3
Differentiation of Hepatocellular Carcinoma from Other Hepatic Malignancies in Patients at Risk: Diagnostic Performance of the Liver Imaging Reporting and Data System Version 2014.
Hepatocellular carcinoma: State of the art diagnostic imaging.
肝细胞癌:最新诊断成像技术
World J Radiol. 2023 Mar 28;15(3):56-68. doi: 10.4329/wjr.v15.i3.56.
4
Massive Hepatocellular Carcinoma with Situs Inversus Totalis Achieved a Complete Response Following Camrelizumab Plus Apatinib and Combined with Two-Stage Hepatectomy: A Case Report.完全性内脏转位合并巨大肝细胞癌经卡瑞利珠单抗联合阿帕替尼治疗并两阶段肝切除术后达到完全缓解:一例报告
Pharmgenomics Pers Med. 2023 Feb 7;16:111-120. doi: 10.2147/PGPM.S376596. eCollection 2023.
5
A Narrative Review on LI-RADS Algorithm in Liver Tumors: Prospects and Pitfalls.关于肝脏肿瘤中LI-RADS算法的叙述性综述:前景与陷阱
Diagnostics (Basel). 2022 Jul 7;12(7):1655. doi: 10.3390/diagnostics12071655.
6
Adapting the Utility of Lipiodol CT in Treating Small Hepatocellular Carcinoma.碘油CT在小肝癌治疗中的应用价值调整
J Clin Exp Hepatol. 2022 Mar-Apr;12(2):664-668. doi: 10.1016/j.jceh.2021.07.012. Epub 2021 Jul 30.
7
Optimizing diagnostic imaging data using LI-RADS and the Likert scale in patients with hepatocellular carcinoma.利用肝脏影像报告和数据系统(LI-RADS)及李克特量表优化肝细胞癌患者的诊断成像数据
Pol J Radiol. 2021 Sep 23;86:e557-e563. doi: 10.5114/pjr.2021.110647. eCollection 2021.
8
Contrast-Enhanced Ultrasonography for Screening and Diagnosis of Hepatocellular Carcinoma: A Case Series and Review of the Literature.超声造影在肝细胞癌筛查与诊断中的应用:病例系列及文献综述
Medicines (Basel). 2020 Aug 27;7(9):51. doi: 10.3390/medicines7090051.
9
Intra-individual consistency of spectral detector CT-enabled iodine quantification of the vascular and renal blood pool.个体内一致性的光谱探测器 CT 增强碘量化的血管和肾血池。
Eur Radiol. 2019 Dec;29(12):6581-6590. doi: 10.1007/s00330-019-06266-w. Epub 2019 Jun 7.
10
Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy?肝细胞癌:钆塞酸增强磁共振和弥散加权成像的 LI-RADS v2017 能否提高诊断准确性?
World J Gastroenterol. 2019 Feb 7;25(5):622-631. doi: 10.3748/wjg.v25.i5.622.
在高危患者中鉴别肝细胞癌与其他肝脏恶性肿瘤:肝脏影像报告和数据系统 2014 版的诊断性能。
Radiology. 2018 Jan;286(1):158-172. doi: 10.1148/radiol.2017170114. Epub 2017 Aug 29.
4
Liver imaging reporting and data system (LI-RADS) version 2014: understanding and application of the diagnostic algorithm.肝脏影像报告和数据系统(LI-RADS)2014版:诊断算法的理解与应用
Clin Mol Hepatol. 2016 Jun;22(2):296-307. doi: 10.3350/cmh.2016.0028.
5
Natural history of liver imaging reporting and data system category 4 nodules in MRI.MRI 中肝脏影像报告和数据系统分类 4 结节的自然史。
Abdom Radiol (NY). 2016 Sep;41(9):1758-66. doi: 10.1007/s00261-016-0762-3.
6
Imaging Outcomes of Liver Imaging Reporting and Data System Version 2014 Category 2, 3, and 4 Observations Detected at CT and MR Imaging.CT 和 MR 成像中检测到的肝脏成像报告和数据系统 2014 版类别 2、3 和 4 观测的成像结果。
Radiology. 2016 Oct;281(1):129-39. doi: 10.1148/radiol.2016152173. Epub 2016 Apr 26.
7
Imaging Features of Biphenotypic Primary Liver Carcinoma (Hepatocholangiocarcinoma) and the Potential to Mimic Hepatocellular Carcinoma: LI-RADS Analysis of CT and MRI Features in 61 Cases.双表型原发性肝癌(肝内胆管癌)的影像学特征及模仿肝细胞癌的可能性:61例CT和MRI特征的LI-RADS分析
AJR Am J Roentgenol. 2016 Jul;207(1):25-31. doi: 10.2214/AJR.15.14997. Epub 2016 Feb 11.
8
How reader perception of capsule affects interpretation of washout in hypervascular liver nodules in patients at risk for hepatocellular carcinoma.读者对胶囊的认知如何影响对有肝细胞癌风险患者的高血管性肝结节洗脱的解读。
J Magn Reson Imaging. 2016 Jun;43(6):1337-45. doi: 10.1002/jmri.25094. Epub 2015 Nov 11.
9
JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan.《日本肝癌研究组基于JSH共识的肝细胞癌管理临床实践指南:2014年更新》
Liver Cancer. 2014 Oct;3(3-4):458-68. doi: 10.1159/000343875.
10
Cirrhotic liver: What's that nodule? The LI-RADS approach.肝硬化肝脏:那个结节是什么?肝脏影像报告和数据系统(LI-RADS)方法。
J Magn Reson Imaging. 2016 Feb;43(2):281-94. doi: 10.1002/jmri.24937. Epub 2015 May 21.